Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

AZD2171 for Refractory Breast Cancer: a Phase 2 Trial

AZD2171 for Refractory Breast Cancer: a Phase 2 Trial. Proceeding of the 2008 Dana-Farber Harvard Cancer Center breast cancer symposium. 2008.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.